Joshua Friedman
Corporate Officer/Principal bij SPYRE THERAPEUTICS, INC.
Actieve functies van Joshua Friedman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 27-11-2023 | - |
Loopbaan van Joshua Friedman
Eerdere bekende functies van Joshua Friedman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2022 | 01-07-2023 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-11-2019 | 01-01-2022 |
Opleiding van Joshua Friedman
| Harvard University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Beurs
- Insiders
- Joshua Friedman
- Ervaring
